Glycemic Control in Patients with Type 2 Diabetes

MOspace/Manakin Repository

Breadcrumbs Navigation

Glycemic Control in Patients with Type 2 Diabetes

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3983

[+] show full item record


Title: Glycemic Control in Patients with Type 2 Diabetes
Author: Glendenning, Charles; Kaufmann, Lee
Keywords: A1C reduction
alpha-glucosidase inhibitors
hypoglycemia
insulin resistance
Date: 2007-04
Publisher: Family Physicians Inquiries Network
Citation: American Family Physician, 75(7) 2007.
Abstract: There is no clearly superior oral agent for glycemic control in patients with type 2 diabetes. (Strength of Recommendation [SOR]: C) Metformin (Glucophage) has shown additional benefit when compared with other treatments (including insulin) for diabetes-related outcomes and all-cause mortality and should be considered the agent of choice for initial monotherapy, particularly in obese patients. (SOR: A)
URI: http://hdl.handle.net/10355/3983

This item appears in the following Collection(s)

[+] show full item record